Dr. Michael M. Lederman, MD

  • Bend, OR
  • Infectious disease specialist
NPI1437175098
Medicare services, 2018
21
Part D claims, 2024
25
Publications
357
Clinical trials
18
Industry payments
$14,677
Practice address
1212 SW Simpson Ave, Bend, OR 97702
Practice phone
Call (216) 844-8500
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Lederman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael M. Lederman is an infectious disease specialist in Bend, Oregon

Dr. Lederman practices in Bend, Oregon.

Dr. Lederman's NPI, 1437175098, was assigned on July 15, 2006. Dr. Lederman graduated from Icahn School Of Medicine At Mount Sinai in 1974. Dr. Lederman holds Ohio license 35-044715.

NPI and contact details
NPI enumeration date
July 15, 2006
NPI status
Active
Practice phone
(216) 844-8500
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1974

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Michael M. Lederman's practice address is in Bend, Oregon

Dr. Lederman's practice address in the NPI Registry is 1212 SW Simpson Ave, Bend, OR 97702, in Deschutes County. The practice phone is (216) 844-8500.

  • NPI Registry address
    1212 SW Simpson Ave, Bend, OR 97702 · Deschutes CountyPhone(216) 844-8500

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Michael M. Lederman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lederman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Lederman's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lederman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael M. Lederman is one of 101 infectious disease specialists in Oregon

Infectious disease is Dr. Lederman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Lederman is board certified in infectious disease by the American Board of Internal Medicine. Dr. Lederman is licensed in Ohio.

Specialties and state licenses

  • Infectious disease, OhioPrimaryLicense 35-044715 · 1980 to 2026 · taxonomy 207RI0200X

Infectious disease specialists near Dr. Lederman

Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.

101infectious disease specialists in Oregon
4infectious disease specialists in Bend

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael M. Lederman billed Medicare for 21 services in 2018

CMS data shows 21 Medicare services from Dr. Lederman across 1 procedure code in 2018, all of them office visits. Medicare paid $1,071 for them. Every service was in an office.

Medicare services, 201821
Paid by Medicare$1,071
Procedure codes1

Dr. Lederman's Medicare services by type, 2017 to 2018

  • 2017
  • 2018
Office and hospital visits
2017: 262018: 2119%

Dr. Lederman compared with the Oregon median for infectious disease specialists, 2018

  • Dr. Lederman
  • Oregon median
Medicare services
21vs 15586% below
Part D claims
258vs 1192.2 times

Medians across 103 infectious disease specialists in Oregon with Dmand AI profiles that report each measure.

Dr. Lederman's most billed Medicare procedure codes, 2018

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lederman

Need commercial claims for Dr. Lederman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lederman and other infectious disease specialists in Oregon.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael M. Lederman wrote 25 Medicare Part D claims in 2024

In 2024, Dr. Lederman wrote 25 Medicare Part D claims. 96% of them were for generic drugs. They cover 11 drugs, with $359,738 in total drug cost. In 2018, CMS named 882 claims across 34 drugs.

Part D claims, 202425
Drugs named by CMS11
Total drug cost$359,738

Dr. Lederman's Part D claims by kind of drug, 2024

  • Generic24 claims96%
  • Brand-name and other1 claims4%

Dr. Lederman's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 8822019: 25871%

Drugs named by CMS: 11 in 2019, 34 in 2018.

See all prescribing by Dr. Lederman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find infectious disease specialists like Dr. Lederman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael M. Lederman has 357 publications on record

Dmand AI links 357 papers to Dr. Lederman, published from 2000 to 2025. 2016 was the busiest year, with 10. The most frequent topics are HIV Infections, HIV-1 and Anti-HIV Agents. Dr. Lederman has published most often in J Infect Dis. Dr. Lederman's most frequent co-authors are Steven Grant Deeks, MD, Peter William Hunt, MD and Wei Jiang, MD.

Papers357
Years published2000 to 2025

Dr. Lederman's papers by year, 2016 to 2025

Topics Dr. Lederman writes about most

  • HIV Infections
  • HIV-1
  • Anti-HIV Agents
  • CD4-Positive T-Lymphocytes
  • CD4 Lymphocyte Count
  • Lymphocyte Activation
  • Viral Load
  • Antiretroviral Therapy, Highly Active

Dr. Lederman's most frequent co-authors

Recent publications by Dr. Lederman

See all 357 publications and co-authors

See who Dr. Lederman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lederman works with, so you can find a warm path to the right infectious disease specialists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael M. Lederman has worked on 18 clinical trials

Dmand AI links Dr. Lederman to 18 clinical trials, 6 of them phase 2 studies. Conditions studied include HIV Infections, Lentivirus Infections and Acquired Immunodeficiency Syndrome. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 12.

Clinical trials with Dr. Lederman by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 1/2: 1 trial
  3. 6Phase 2: 6 trials
  4. NonePhase 3: no trials
  5. 2Phase 4: 2 trials

Conditions in Dr. Lederman's trials

  • HIV Infections
  • Lentivirus Infections
  • Acquired Immunodeficiency Syndrome
  • AIDS-Related Complex
  • AIDS-Associated Nephropathy

Investigators on the most trials with Dr. Lederman

Recent clinical trials with Dr. Lederman

See all 18 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Michael M. Lederman received $14,677 in industry payments from 2016 to 2022

CMS Open Payments shows 45 general payments to Dr. Lederman from 5 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $8,529.

General payments to Dr. Lederman by program year, 2016 to 2022

General payments to Dr. Lederman by kind, 2016 to 2022

$14.7Kin total
  • Consulting fees$11,77580%
  • Travel and lodging$2,17415%
  • Food and beverage$7285%

Companies that paid Dr. Lederman the most, 2016 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Lederman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael M. Lederman graduated from Icahn School Of Medicine At Mount Sinai

Dr. Lederman graduated from Icahn School Of Medicine At Mount Sinai in 1974.

  1. Medical schoolIcahn School Of Medicine At Mount Sinai
  2. Board certified in infectious diseaseAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Michael M. Lederman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael M. Lederman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael M. Lederman's NPI number?

Dr. Michael M. Lederman's NPI number is 1437175098. It was assigned on July 15, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael M. Lederman?

Dr. Michael M. Lederman is an infectious disease specialist in Bend, Oregon. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).

Where does Dr. Michael M. Lederman practice?

Dr. Lederman practices at 1212 SW Simpson Ave, Bend, OR 97702.

What is Dr. Michael M. Lederman's office phone number?

The practice phone on file for Dr. Lederman is (216) 844-8500.

What is Dr. Michael M. Lederman's medical license number?

Dr. Lederman holds Ohio license 35-044715.

Does Dr. Michael M. Lederman accept Medicare?

Yes. CMS data shows Dr. Lederman billed Medicare for 21 services in 2018.

Is Dr. Michael M. Lederman board certified?

Yes. Dr. Lederman is board certified in infectious disease by the American Board of Internal Medicine.

What services does Dr. Michael M. Lederman bill to Medicare?

In 2018, Dr. Lederman's most billed Medicare services were office visit, established patient (99214).

Where did Dr. Michael M. Lederman go to medical school?

Dr. Lederman graduated from Icahn School Of Medicine At Mount Sinai in 1974.

What drugs does Dr. Michael M. Lederman prescribe most?

In 2019 Medicare Part D data, Dr. Lederman's most prescribed drugs by claims were Tivicay, Descovy and Triumeq.

Show 4 more questionsShow fewer questions

Has Dr. Michael M. Lederman received payments from drug or device companies?

CMS Open Payments shows $14,677 in general payments to Dr. Lederman from 5 companies from 2016 to 2022. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Michael M. Lederman been practicing?

Dr. Lederman graduated from medical school in 1974, 52 years ago.

Does Dr. Michael M. Lederman do research?

Dmand AI links 357 publications to Dr. Lederman, published from 2000 to 2025. Dr. Lederman has worked on 18 clinical trials.

Who does Dr. Michael M. Lederman publish with?

Dr. Lederman's most frequent co-authors are Steven Grant Deeks, MD (23 shared papers), Peter William Hunt, MD (20 shared papers) and Wei Jiang, MD (11 shared papers).

Selling to infectious disease practices?

See infectious disease specialists in Oregon by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)